Clinical Trial: TSI and Its Relationship With Graves' Disease Relapse
Study Status: Completed
Recruit Status: Completed
Condition:
Graves Disease
Immunoglobulin
Anti-Thyroid Antibodies Disorder
Study Type: Observational
Official Title: Thyroid-stimulating Immunoglobulins Level in Patients With Graves' Disease Undergoing Maintenance-dose of Antithyroid Drug and Its Relationship With Disease Relapse
Brief Summary:
The goal of this observational study is to determine the role of TSI, as well as clinical signs and thyroid function tests in predicting Graves' disease (GD) relapse after withdrawing anti thyroid drug (ATD). The main questions it aims to answer are:To investigate the serum TSI concentration in patients with GD undergoing maintenance-dose ATD.To determine an optimal cut-off of TSI level for predicting GD relapse.To determine the role of TSI in predicting Graves' disease relapse after withdrawing ATD.
Read more